Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders

Area of Science:

• Immunology
• Hematology
• Transplantation

Background:

• Primary immunodeficiency disorders (PIDs) are genetic conditions impairing the immune system, leading to severe infections and autoimmunity.
• Hematopoietic cell transplant (HCT) is a curative treatment for many PIDs, but outcomes are variable.
• Severe combined immunodeficiency (SCID) requires early HCT, presenting unique challenges.

Purpose of the Study:

• To review the unique challenges and evidence-based approaches for HCT in patients with PIDs.
• To discuss the impact of donor source and conditioning regimens on immune reconstitution after HCT for PIDs.

Main Methods:

• Review of existing literature on HCT for primary immunodeficiency disorders.
• Analysis of factors influencing immune reconstitution, including donor selection and conditioning protocols.
• Discussion of challenges related to engraftment variability and radiosensitive PIDs.

Main Results:

• Donor source (matched/unmatched, related/unrelated) and conditioning regimens significantly affect HCT outcomes in PIDs.
• Engraftment success varies among lymphocyte subpopulations, even within the same patient.
• Alkylating agents must be avoided in radiosensitive PIDs due to potential toxicity.

Conclusions:

• HCT for PIDs requires tailored strategies considering donor source and conditioning regimens.
• Optimizing HCT protocols is crucial for successful immune reconstitution in PIDs.
• Further research is needed to refine HCT approaches for these rare disorders.